Immucell Corp (ICCC) Stock Price, Quote & News

Company Profile

ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments: Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus...

Industry: Biotechnology

Sector: Healthcare

Phone: 207 878 2770

Website: immucell.com

Address:

56 Evergreen Drive, Portland, United States

Paper_Route_Frank Jan. 17 at 1:23 PM

$ICCC avg 6.44 light position

0 · Reply

BillionerOfKing Jan. 16 at 8:02 PM

$ICCC Current Stock Price: $6.27

0 · Reply

ZacksResearch Jan. 15 at 4:38 PM

Niche healthcare is where the real edge is forming 👀 $CPIX, $NAII and $ICCC are carving out durable lanes while others fight crowded markets. These firms are leaning into specialization, regulatory compliance, and targeted growth to compete — a strategy that’s proving effective in niche healthcare segments where focus matters most. See how niche focus and regulation are shaping the winners 👉 https://www.zacks.com/stock/news/2818242/niche-focus-regulation-shape-the-future-of-healthcare-firms?cid=sm-stocktwits-2-2818242-teaser-29118&ADID=SYND_STOCKTWITS_TWEET_2_2818242_TEASER_29118

0 · Reply

raventhemonkey Jan. 8 at 11:35 PM

$ICCC $7.15 after hours GLTA

0 · Reply

TommyTwenty Jan. 6 at 6:34 PM

$ICCC hoping this little run is in anticipation of some good news with the pop-up conference call at the end of the week.

1 · Reply

theRooster007 Jan. 2 at 5:10 PM

$ICCC 🥛

0 · Reply

SuperGreenToday Dec. 30 at 12:36 AM

$ICCC

0 · Reply

DARKP00L Dec. 29 at 1:48 PM

$ICCC 08:15 on Dec. 29 2025 ImmuCell Pauses Re-Tain Drug After FDA Setback, Shifts Focus to Expanding First Defense Business #tradeideas

0 · Reply

DARKP00L Dec. 29 at 1:20 PM

$ICCC 08:15 on Dec. 29 2025 ImmuCell Pauses Re-Tain Drug After FDA Setback, Shifts Focus to Expanding First Defense Business #tradeideas

0 · Reply

BioTechHealthX Dec. 28 at 1:01 AM

$ICCC ImmuCell Corporation (NASDAQ:ICCC) develops and manufactures animal health products that improve cattle health and productivity across dairy and beef operations. This background deep dive explains how First Defense became a scours prevention leader, why manufacturing equipment and quality matter in animal health, and why ICCC is showing up on more Nasdaq watchlists. https://biotechhealthx.com/biotech-news/immucell-corporation-iccc-is-quietly-building-an-animal-health-powerhouse-most-investors-arent-watching-yet/

0 · Reply

ImmuCell Corporation (ICCC) Q4 2025 Sales/Trading Call Transcript

Jan 8, 2026, 4:05 PM EST - 21 days ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025

Jan 7, 2026, 8:10 AM EST - 22 days ago

ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus

Dec 24, 2025, 1:05 PM EST - 5 weeks ago

ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain®

Nov 14, 2025, 11:01 AM EST - 2 months ago

ImmuCell Corporation (ICCC) Q3 2025 Earnings Call Transcript

Nov 13, 2025, 4:05 PM EST - 2 months ago

ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025

Nov 6, 2025, 4:05 PM EST - 3 months ago

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2025

Nov 4, 2025, 4:05 PM EST - 3 months ago

ImmuCell Announces Onboarding of New CEO and Related Management Changes

Oct 7, 2025, 4:05 PM EDT - 4 months ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 of 2025

Sep 29, 2025, 4:05 PM EDT - 4 months ago

ImmuCell Announces Selection of its Next President and CEO

Aug 15, 2025, 11:04 AM EDT - 5 months ago

ImmuCell Corporation (ICCC) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 4:05 PM EDT - 6 months ago

ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2025

Aug 12, 2025, 4:05 PM EDT - 6 months ago

ImmuCell Announces Bank Debt Refinancing

Aug 7, 2025, 8:00 AM EDT - 6 months ago

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2025

Jul 9, 2025, 8:00 AM EDT - 7 months ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 of 2025

Jun 25, 2025, 8:00 AM EDT - 7 months ago

ImmuCell Embarks on CEO Succession Planning Process

Jun 5, 2025, 6:30 AM EDT - 8 months ago

ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders

May 15, 2025, 10:19 AM EDT - 9 months ago

ImmuCell Corporation (ICCC) Q1 2025 Earnings Call Transcript

May 14, 2025, 4:05 PM EDT - 9 months ago

ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2025

May 12, 2025, 8:42 AM EDT - 9 months ago

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2025

Apr 8, 2025, 4:05 PM EDT - 10 months ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025

Apr 2, 2025, 4:05 PM EDT - 10 months ago

ImmuCell Announces Initiation of Investigational Product Use of Re-Tain®

Feb 26, 2025, 11:44 AM EST - 1 year ago

ImmuCell Corporation (ICCC) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 4:05 PM EST - 1 year ago

ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2024

Feb 20, 2025, 8:19 AM EST - 1 year ago

ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2024

Jan 16, 2025, 4:05 PM EST - 1 year ago

ImmuCell Announces Settlement of Insurance Claim Related to Previously Disclosed Production Contamination Losses

Jan 9, 2025, 4:05 PM EST - 1 year ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year 2024

Nov 14, 2024, 11:09 AM EST - 1 year ago

ImmuCell Corporation (ICCC) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 4:05 PM EST - 1 year ago

ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2024

Nov 7, 2024, 8:30 AM EST - 1 year ago

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024

Oct 8, 2024, 4:05 PM EDT - 1 year ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024

Aug 14, 2024, 12:18 PM EDT - 1 year ago

ImmuCell Corporation (ICCC) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 4:05 PM EDT - 1 year ago

ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024

Aug 7, 2024, 4:05 PM EDT - 1 year ago

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2024

Jul 9, 2024, 4:05 PM EDT - 1 year ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024

Jun 5, 2024, 4:05 PM EDT - 1 year ago

ImmuCell Provides Update on Regulatory Status of Product Development Initiative for Re-Tain®

May 15, 2024, 1:48 PM EDT - 1 year ago

ImmuCell Corporation (ICCC) Q1 2024 Earnings Call Transcript

May 14, 2024, 4:05 PM EDT - 1 year ago

ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024

May 8, 2024, 1:00 PM EDT - 1 year ago

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024

Apr 9, 2024, 4:05 PM EDT - 1 year ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024

Feb 28, 2024, 11:58 AM EST - 2 years ago

ImmuCell Corporation (ICCC) Q4 2023 Earnings Call Transcript

Feb 27, 2024, 4:05 PM EST - 2 years ago

ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023

Feb 16, 2024, 9:30 AM EST - 2 years ago

ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023

Jan 8, 2024, 4:05 PM EST - 2 years ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023

Nov 14, 2023, 2:36 PM EST - 2 years ago

ImmuCell Corporation (ICCC) Q3 2023 Earnings Call Transcript

Nov 13, 2023, 4:05 PM EST - 2 years ago

ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023

Nov 7, 2023, 12:15 PM EST - 2 years ago

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023

Oct 5, 2023, 4:05 PM EDT - 2 years ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023

Aug 29, 2023, 8:00 AM EDT - 2 years ago

ImmuCell Announces Submission of CMC Technical Section to the FDA

Aug 11, 2023, 4:48 PM EDT - 2 years ago

ImmuCell Corporation (ICCC) Q2 2023 Earnings Call Transcript

Paper_Route_Frank Jan. 17 at 1:23 PM

$ICCC avg 6.44 light position

0 · Reply

BillionerOfKing Jan. 16 at 8:02 PM

$ICCC Current Stock Price: $6.27

0 · Reply

ZacksResearch Jan. 15 at 4:38 PM

0 · Reply

raventhemonkey Jan. 8 at 11:35 PM

$ICCC $7.15 after hours GLTA

0 · Reply

TommyTwenty Jan. 6 at 6:34 PM

$ICCC hoping this little run is in anticipation of some good news with the pop-up conference call at the end of the week.

1 · Reply

theRooster007 Jan. 2 at 5:10 PM

$ICCC 🥛

0 · Reply

SuperGreenToday Dec. 30 at 12:36 AM

$ICCC

0 · Reply

DARKP00L Dec. 29 at 1:48 PM

$ICCC 08:15 on Dec. 29 2025 ImmuCell Pauses Re-Tain Drug After FDA Setback, Shifts Focus to Expanding First Defense Business #tradeideas

0 · Reply

DARKP00L Dec. 29 at 1:20 PM

$ICCC 08:15 on Dec. 29 2025 ImmuCell Pauses Re-Tain Drug After FDA Setback, Shifts Focus to Expanding First Defense Business #tradeideas

0 · Reply

BioTechHealthX Dec. 28 at 1:01 AM

0 · Reply

StocktwitsNews Dec. 26 at 5:38 PM

The Christmas Party Is Still Ongoing In These Stocks: Nvidia, Sidus Space, Coupang, Vanda Pharmaceuticals, ImmuCell $NVDA $SIDU $CPNG $VNDA $ICCC https://stocktwits.com/news/equity/markets/christmas-party-stocks-still-ongoing-2025/cLeULetRED2

0 · Reply

Few_erish Dec. 26 at 4:34 PM

$ICCC Small tape, big move, 6.11 up 5.34 but only 193,173 volume, that’s thin liquidity so every print matters

0 · Reply

UnicornPicks Dec. 26 at 2:42 PM

$ICCC $OPTX $PPSI $SIDU ideas for scalp!

0 · Reply

DARKP00L Dec. 26 at 2:37 PM

$ICCC 09:31 on Dec. 26 2025 ImmuCell Puts Re-Tain On Pause After FDA Letter #tradeideas

0 · Reply

Stock_Catcher Dec. 26 at 2:33 PM

$ICCC thin one

0 · Reply

OpenOutcrier Dec. 26 at 1:11 PM

$ICCC (-11.7% pre) ImmuCell pauses Re-Tain development after FDA rejection, shifts to First Defense https://ooc.bz/l/88396

0 · Reply

InterpolationIsle Dec. 25 at 4:57 PM

$ICCC Market behavior suggests the name is transitioning from speculation toward proof‑based evaluation. The business must show that scaling does not introduce uncontrolled risk. Failure to deliver would likely trigger renewed valuation compression. Over time, credibility will hinge on repeatable performance.

1 · Reply

Bogwood Dec. 24 at 6:20 PM

$ICCC 🤢🤮

0 · Reply

TommyTwenty Dec. 16 at 12:45 AM

$ICCC https://rollcall.com/2025/12/15/house-clears-whole-milk-for-school-menus/

0 · Reply

CEOBuysDisclosures Dec. 4 at 11:15 PM

$ICCC CEO purchased 6,030 shares at $5.23 for a total of $31,528. te Boekhorst Paul Francis Olivier now owns 9,738 shares. https://ceo-buys.com

0 · Reply

theRooster007 Dec. 4 at 8:36 PM

$ICCC

0 · Reply

ZacksResearch Dec. 4 at 4:16 PM

$ICCC’s cattle-health play is starting to look like a quiet breakout story. Their two antibiotic-free products are driving margin recovery and real-world adoption — and the stock is already reacting. See the full setup here 👉 https://www.zacks.com/stock/news/2799680/immucells-two-product-edge-in-cattle-health-fuels-growth?cid=sm-stocktwits-2-2799680-teaser-23445&ADID=SYND_STOCKTWITS_TWEET_2_2799680_TEASER_23445

0 · Reply

Market Cap	57.58M
Revenue (ttm)	26.49M
Net Income (ttm)	-2.16M
EPS (ttm)	N/A
PE Ratio	24.10
Forward PE	N/A
Profit Margin	-8.15%
Debt to Equity Ratio	0.32

Volume	53,600
Avg Vol	28,042
Day's Range	N/A - N/A
Shares Out	9.05M
Stochastic %K	0%
Beta	0.18
Analysts	Strong Buy
Price Target	$14.00